Soin Bio

Soin Therapeutics is a clinical-stage pharmaceutical company focused on developing novel treatments for chronic pain and rare diseases. The company's lead candidate, ST-2427, is a non-opioid, selective sodium channel inhibitor designed to treat conditions such as Complex Regional Pain Syndrome (CRPS) and erythromelalgia. By targeting specific sodium channels involved in pain signaling, Soin Therapeutics aims to provide effective analgesia without the addiction risks associated with opioids. The company is also exploring applications for its technology in post-operative pain management and other neuropathic pain conditions.